MDT Stock Recent News

Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.

Dividend stocks that offer high yields can be gold mines for your portfolio as they can generate loads of recurring income for you for years. Whether you want to use the money to reinvest in those stocks or simply use the dividend income to help add to your cash position, they can make for great long-term investments to have.

Medtronic plc (NYSE:MDT ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Okay. Good morning.

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn. , Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo™ robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.

GALWAY, Ireland , Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes.

GALWAY, Ireland , Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m.

Medtronic MDT has been trapped in a tight consolidation band for what feels like forever. For more than 1,100 days, the stock has stubbornly stayed between $75 and $95, showing little sign of life.

ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Dividend investing can be tricky, since income-focused investors want to find high yields while also avoiding stocks that end up cutting their quarterly payouts. There's a balance that has to be found, and company quality is highly important to consider.